Skip to main content
Top
Published in: Clinical and Experimental Nephrology 6/2012

01-12-2012 | Original Article

Comparison between serum free triiodothyronine levels and body fluid distribution in hemodialysis patients

Authors: Osamu Saito, Takako Saito, Koshi Ueno, Takeshi Shiraishi, Takanori Kikuchi, Hisashi Yamamoto, Tetsu Akimoto, Yasuhiro Ando, Shigeaki Muto, Eiji Kusano

Published in: Clinical and Experimental Nephrology | Issue 6/2012

Login to get access

Abstract

Aim

Low free triiodothyronine (fT3) has been associated with the presence of malnutrition–inflammation syndrome in patients with end-stage renal disease (ESRD) and decreased overall survival in ESRD. Since thyroid hormone has a particular effect on body fluid status, we hypothesized that hemodialysis patients with low-T3 syndrome might have interstitial edema. In this study, we examined the relationship between levels of thyroid hormone and body composition parameters in Japanese hemodialysis patients.

Methods

The subjects were 52 patients on maintenance hemodialysis. Serum levels of thyroid hormone and atrial natriuretic peptide (hANP) were measured. Body composition parameters were measured using a bioimpedance body composition analyzer.

Results

Serum fT3 had positive correlations with body mass index (BMI), body fat mass (BFM), total body water (TBW) and intracellular water (ICW), and negative correlations with the ratio of extracellular water to total body water (ECW/TBW) and hANP. There were no correlations between serum fT4 and any body composition parameter. The 49 patients with data at baseline and after 1 year were divided into groups with increased (n = 33) and decreased (n = 16) fT3 after 1 year. ΔBMI and ΔBFM were significantly lower and ΔTBW, ΔICW, ΔECW and ΔECW/TBW (changes over 1 year from baseline) were significantly higher in patients with decreased fT3 compared to those with increased fT3. There was no significant difference in ΔhANP or Δcardiothoracic ratio between the two groups.

Conclusion

These results show that a decrease in fT3 might be associated with emaciation and interstitial edema in Japanese hemodialysis patients.
Literature
1.
go back to reference Hierholzer K, Finke R. Myxedema. Kidney Int Suppl. 1997;59:S82–9.PubMed Hierholzer K, Finke R. Myxedema. Kidney Int Suppl. 1997;59:S82–9.PubMed
2.
go back to reference Montenegro J, Gonzalez O, Saracho R, Aguirre R, Gonzalez O, Martinez I. Changes in renal function in primary hypothyroidism. Am J Kidney Dis. 1996;27:195–8.PubMedCrossRef Montenegro J, Gonzalez O, Saracho R, Aguirre R, Gonzalez O, Martinez I. Changes in renal function in primary hypothyroidism. Am J Kidney Dis. 1996;27:195–8.PubMedCrossRef
3.
go back to reference Villabona C, Sahun M, Roca M, Mora J, Gomez N, Gomez JM, et al. Blood volumes and renal function in overt and subclinical primary hypothyroidism. Am J Med Sci. 1999;318:277–80.PubMedCrossRef Villabona C, Sahun M, Roca M, Mora J, Gomez N, Gomez JM, et al. Blood volumes and renal function in overt and subclinical primary hypothyroidism. Am J Med Sci. 1999;318:277–80.PubMedCrossRef
4.
go back to reference Sartorio A, Malavolti M, Agosti F, Marinone PG, Caiti O, Battistini N, et al. Body water distribution in severe obesity and its assessment from eight-polar bioelectrical impedance analysis. Eur J Clin Nutr. 2004;1:1–6. Sartorio A, Malavolti M, Agosti F, Marinone PG, Caiti O, Battistini N, et al. Body water distribution in severe obesity and its assessment from eight-polar bioelectrical impedance analysis. Eur J Clin Nutr. 2004;1:1–6.
5.
go back to reference Chertow GM, Lowrie EG, Wilmore DW, Gonzale J, Lew NL, Ling J, et al. Nutritional assessment with bioelectrical impedance analysis in maintenance hemodialysis patients. J Am Soc Nephrol. 1995;6:75–81.PubMed Chertow GM, Lowrie EG, Wilmore DW, Gonzale J, Lew NL, Ling J, et al. Nutritional assessment with bioelectrical impedance analysis in maintenance hemodialysis patients. J Am Soc Nephrol. 1995;6:75–81.PubMed
6.
go back to reference Di Iorio BR, Scalfi L, Terracciano V, Bellizzi V. A systemic evaluation of bioelectrical impedance measurement after hemodialysis session. Kidney Int. 2004;65:2435–40. Di Iorio BR, Scalfi L, Terracciano V, Bellizzi V. A systemic evaluation of bioelectrical impedance measurement after hemodialysis session. Kidney Int. 2004;65:2435–40.
7.
go back to reference Spiegel DM, Bashir K, Fisch B. Bioimpedance resistance ratios for the evaluation of dry weight in hemodialysis. Clin Nephrol. 2000;53:108–14.PubMed Spiegel DM, Bashir K, Fisch B. Bioimpedance resistance ratios for the evaluation of dry weight in hemodialysis. Clin Nephrol. 2000;53:108–14.PubMed
8.
go back to reference Lo JC, Chertow GM, Go AS, Hsu CY. Increased prevalence of subclinical and clinical hypothyroidism in persons with chronic kidney disease. Kidney Int. 2005;67:1047–52.PubMedCrossRef Lo JC, Chertow GM, Go AS, Hsu CY. Increased prevalence of subclinical and clinical hypothyroidism in persons with chronic kidney disease. Kidney Int. 2005;67:1047–52.PubMedCrossRef
9.
go back to reference Lim V, Flanigan M, Zavala D, Freeman R. Protective adaptation of low serum triiodothyronine in patients with chronic renal failure. Kidney Int. 1985;28:541–9.PubMedCrossRef Lim V, Flanigan M, Zavala D, Freeman R. Protective adaptation of low serum triiodothyronine in patients with chronic renal failure. Kidney Int. 1985;28:541–9.PubMedCrossRef
10.
go back to reference Zoccali C, Mallamaci F, Tripepi G, Cutrupi S, Pizzini P. Low triiodothyronine and survival in end-stage renal disease. Kidney Int. 2006;70:523–8.PubMed Zoccali C, Mallamaci F, Tripepi G, Cutrupi S, Pizzini P. Low triiodothyronine and survival in end-stage renal disease. Kidney Int. 2006;70:523–8.PubMed
11.
go back to reference Iseki K, Tozawa M, Takishita S. Determinants of prescribed dialysis dose and survival in a cohort of chronic hemodialysis patients. Clin Exp Nephrol. 2003;7:231–7.PubMedCrossRef Iseki K, Tozawa M, Takishita S. Determinants of prescribed dialysis dose and survival in a cohort of chronic hemodialysis patients. Clin Exp Nephrol. 2003;7:231–7.PubMedCrossRef
12.
go back to reference Cha K, Chertow GM, Gonzalez J, Lazarus JM, Wilmore DW. Multifrequency bioelectrical impedance estimates the distribution of body water. J Appl Physiol. 1995;79:1316–9.PubMed Cha K, Chertow GM, Gonzalez J, Lazarus JM, Wilmore DW. Multifrequency bioelectrical impedance estimates the distribution of body water. J Appl Physiol. 1995;79:1316–9.PubMed
13.
go back to reference Lee SW, Song JH, Kim GA, Lee KJ, Kim MJ. Assessment of total body water from anthropometry-based equation using bioelectrical impedance as reference in Korea adult control and hemodialysis subjects. Nephrol Dial Transplant. 2001;16:91–7.PubMedCrossRef Lee SW, Song JH, Kim GA, Lee KJ, Kim MJ. Assessment of total body water from anthropometry-based equation using bioelectrical impedance as reference in Korea adult control and hemodialysis subjects. Nephrol Dial Transplant. 2001;16:91–7.PubMedCrossRef
14.
go back to reference Douyon L, Schteingart DE. Effect of obesity and starvation on thyroid hormone, growth hormone, and cortisol secretion. Endocrinol Metab Clin N Am. 2002;31:173–89.CrossRef Douyon L, Schteingart DE. Effect of obesity and starvation on thyroid hormone, growth hormone, and cortisol secretion. Endocrinol Metab Clin N Am. 2002;31:173–89.CrossRef
15.
go back to reference Zoccali C, Tripepi G, Cutrupi S, Pizzini P, Mallamaci F. Low triiodothyronine: a new facet of inflammation in end-stage renal disease. J Am Soc Nephrol. 2005;16:2789–95.PubMedCrossRef Zoccali C, Tripepi G, Cutrupi S, Pizzini P, Mallamaci F. Low triiodothyronine: a new facet of inflammation in end-stage renal disease. J Am Soc Nephrol. 2005;16:2789–95.PubMedCrossRef
16.
go back to reference Boelen A, Platvoet-Ter Schiphorst MC, Wiersinga WM. Association between serum interleukin-6 and serum 3,5,3′-triiodothyronine in nonthyroidal illness. J Clin Endocrinol Metab. 1993;77:1695–9.PubMedCrossRef Boelen A, Platvoet-Ter Schiphorst MC, Wiersinga WM. Association between serum interleukin-6 and serum 3,5,3′-triiodothyronine in nonthyroidal illness. J Clin Endocrinol Metab. 1993;77:1695–9.PubMedCrossRef
17.
go back to reference Chan C, Mclntyre C, Smith D, Spanel P, Davis SJ. Combining near-subject absolute and relative measures of longitudinal hydration in hemodialysis. Clin J Am Soc Nephrol. 2009;4:1791–8.PubMedCrossRef Chan C, Mclntyre C, Smith D, Spanel P, Davis SJ. Combining near-subject absolute and relative measures of longitudinal hydration in hemodialysis. Clin J Am Soc Nephrol. 2009;4:1791–8.PubMedCrossRef
18.
go back to reference Lopot F, Nejedly B, Novotna HM, Mackova M, Sulkova S. Age-related extracellular to total body water volume ratio (ECV/TBW)-can it be used for “dry weight” determination in dialysis patients? Application of multifrequency bioimpedance measurement. Int J Artif Organs. 2002;25:762–9.PubMed Lopot F, Nejedly B, Novotna HM, Mackova M, Sulkova S. Age-related extracellular to total body water volume ratio (ECV/TBW)-can it be used for “dry weight” determination in dialysis patients? Application of multifrequency bioimpedance measurement. Int J Artif Organs. 2002;25:762–9.PubMed
19.
go back to reference Cheigh JS, Serur D, Paguirigan M, Stenzel KH, Rubin A. How well is hypertension controlled in CAPD patients. Adv Perit Dial. 1994;10:55–8.PubMed Cheigh JS, Serur D, Paguirigan M, Stenzel KH, Rubin A. How well is hypertension controlled in CAPD patients. Adv Perit Dial. 1994;10:55–8.PubMed
20.
go back to reference Plum J, Grabensee B. Atrial natriuretic peptide in dialysis patients under various conditions of volume homeostasis. J Intern Med. 1991;229:209–16.PubMedCrossRef Plum J, Grabensee B. Atrial natriuretic peptide in dialysis patients under various conditions of volume homeostasis. J Intern Med. 1991;229:209–16.PubMedCrossRef
21.
go back to reference Mandelbaum A, Link A, Wambach G, Ritz E. Vena cava ultrasonography for the assessment of hydration status in kidney insufficiency. Dtsch Med Wochenschr. 1993;118:1309–15.PubMedCrossRef Mandelbaum A, Link A, Wambach G, Ritz E. Vena cava ultrasonography for the assessment of hydration status in kidney insufficiency. Dtsch Med Wochenschr. 1993;118:1309–15.PubMedCrossRef
22.
go back to reference Wilkins MR, Wood JA, Adu D, Lote CJ, Kendall MJ, Michael J. Change in plasma immunoreactive atrial natriuretic peptide during sequential ultrafiltration and haemodialysis. Clin Sci. 1986;71:157–60.PubMed Wilkins MR, Wood JA, Adu D, Lote CJ, Kendall MJ, Michael J. Change in plasma immunoreactive atrial natriuretic peptide during sequential ultrafiltration and haemodialysis. Clin Sci. 1986;71:157–60.PubMed
23.
go back to reference Iervasi G, Pingitore A, Landi P, Raciti P, Ripoli A, Scarlattin M, et al. Low-T3 syndrome: a strong prognostic predictor of death in patients with heart disease. Circulation. 2003;107:708–13.PubMedCrossRef Iervasi G, Pingitore A, Landi P, Raciti P, Ripoli A, Scarlattin M, et al. Low-T3 syndrome: a strong prognostic predictor of death in patients with heart disease. Circulation. 2003;107:708–13.PubMedCrossRef
24.
Metadata
Title
Comparison between serum free triiodothyronine levels and body fluid distribution in hemodialysis patients
Authors
Osamu Saito
Takako Saito
Koshi Ueno
Takeshi Shiraishi
Takanori Kikuchi
Hisashi Yamamoto
Tetsu Akimoto
Yasuhiro Ando
Shigeaki Muto
Eiji Kusano
Publication date
01-12-2012
Publisher
Springer Japan
Published in
Clinical and Experimental Nephrology / Issue 6/2012
Print ISSN: 1342-1751
Electronic ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-012-0648-9

Other articles of this Issue 6/2012

Clinical and Experimental Nephrology 6/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine